Fake medicines flourish in Africa despite killing thousands

January 17, 2018 by Christophe Koffi
Celebrities have joined the fight against fake medications, including South African singer Yvonne Chaka

There's nothing covert about Roxy—a huge market in Abidjan selling counterfeit medicine, the scourge of Africa and the cause of around 100,000 deaths annually on the world's poorest continent.

Located in the bustling Adjame quarter of Ivory Coast's main city and commercial hub, the haven for fake medicine has been targeted time and again by authorities and stockpiles burnt.

But it resurfaces every time.

"The police hassle us but they themselves buy these medicines," said Mariam, one of the many mainly illiterate vendors who hawk everything from painkillers and antibiotics to anti-malaria and anti-retroviral treatments.

"When we are harassed we always come to an arrangement with them to resume our activities," she said.

Fatima, another hawker, said: "Many people come here with their prescriptions to buy medicine, even the owners of private clinics."

She said there was a "syndicate" controlling the sector that held regular meetings to fix prices and supply levels.

Fake medicines bring about some 100,000 deaths a year in the continent, according to the World Health Organization (WHO).

The illicit sector has a turnover of at least 10 percent of the world pharmaceutical business, meaning that it earns tens of billions of dollars a year, the Switzerland-based World Economic Forum estimates, adding that the figure has nearly tripled in five years.

Counterfeit medical pills from India seized in Belgium. Fake drugs from India and China are awash in African markets

"To sell fake medicines, you need a clientele. The ailing poor are more numerous in Africa than anywhere in the world," said Marc Gentilini, an expert on infectious and tropical diseases and a former head of the French Red Cross.

Double-edged crime

Gentilini said some meningitis vaccines sent a few years ago after an outbreak in arid Niger were fake. The disease kills thousands every year in the arid west African nation.

The WHO estimates that one out of 10 medicines in the world is fake but the figure can be as high as seven out of 10 in certain countries, especially in Africa.

The American Society of Tropical Medicine and Hygiene estimated in 2015 that 122,000 children under five died due to taking poor-quality antimalarials in sub-Saharan Africa, which, along with antibiotics as the two most in-demand, are the medicines most likely to be out-of-date or bad copies.

Interpol in August announced the seizure of 420 tonnes of counterfeit medicine in West Africa in a massive operation that involved about 1,000 police, customs and health officials in seven countries: Benin, Burkina Faso, Ivory Coast, Mali, Niger, Nigeria and Togo.

Geoffroy Bessaud, the head of anti-counterfeit coordination at French pharmaceutical giant Sanofi, said fake medicines the were the biggest illicit business in the world.

"This phenomenon is spreading: its financial attractiveness draws criminal organisations of all sizes," he said.

Fake drugs being sold in the Madagascar capital Antananarivo

"An investment of $1,000 can bring returns of up to $500,000 while for the same kind of investment in the heroin trade or in counterfeit money the amount will be around $20,000."

Ivorian authorities in May burnt 40 tonnes of fake medicines in Adjame, the biggest street market for fake medicines in West Africa which accounts for 30 percent of medicine sales in Ivory Coast.

Offenders go unpunished

Offenders remain largely unpunished worldwide and are mainly targeted for breaching intellectual property rights instead of being responsible for the deaths of hundreds of thousands of people, the Paris-based International Institute of Research Against Counterfeit Medicine says.

Experts have called for a global fight against the scourge.

Sanofi said it had in 2016 helped dismantle 27 clandestine laboratories, including 22 in China and the rest in Indonesia, Ukraine and Poland.

In countries where medical expenses—from drugs to hospitalisation—are not even partly reimbursed by the state, the relatively cheap price of street medication trumps the risk factor for many.

The outstanding exception on the continent in fighting the illicit drug trade is South Africa, which has a strictly-enforced licencing system.

Explore further: Ivory Coast breaks up huge fake drugs market

Related Stories

Ivory Coast breaks up huge fake drugs market

May 3, 2017
Ivory Coast authorities deployed dozens of police Wednesday to break up a fake drugs market in Abidjan estimated to supply nearly a third of all treatments sold in the country.

UN: About 11 percent of drugs in poor countries are fake

November 28, 2017
About 11 percent of medicines in developing countries are counterfeit and likely responsible for the deaths of tens of thousands of children from diseases like malaria and pneumonia every year, the World Health Organization ...

Interpol deal with drug firms to fight fake medicines

March 12, 2013
Interpol on Tuesday announced a deal with the world's top pharmaceutical companies to fight fake drugs which threaten the health of millions, especially in poor countries.

Counterfeit medicine trade targets Africa's poor

August 22, 2013
From Cameroon to Ivory Coast, Kenya to the DR Congo, traders in counterfeit drugs do a thriving business with the utmost cynicism and sometimes at the cost of human lives.

Interpol call for roadmap to tackle fake drugs

November 19, 2014
Interpol on Wednesday called for a greater global response to pharmaceutical crime as it warned criminal gangs were capitalising on weaknesses in legislation and border controls.

Internet led to global 'explosion' of fake drugs

June 14, 2012
The rapid growth of Internet commerce has led to an explosion of counterfeit drugs sold around the world, with China the biggest source of fake medicines, pharmaceutical experts said Thursday.

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.